Clinical trials
Active, not recruiting Phase 1 Leukemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seattle Children's Hospital | 3 |
| Bellicum Pharmaceuticals | 2 |
| Dana-Farber Cancer Institute | 2 |
| Baylor College of Medicine | 1 |
| Fate Therapeutics | 1 |
| Genmab | 1 |
| Loyola University | 1 |
| M.D. Anderson Cancer Center | 1 |
| Massachusetts General Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 20 |
| Lymphoma | 8 |
| Myelodysplastic Syndromes | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Multiple Myeloma | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, B-Cell | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.